Dr. Christine Isabel Clavell, MD

Dr. Clavell practices at Eye Associates of New Mexico in Rio Rancho, New Mexico.

Dr. Clavell's NPI, 1124382056, was assigned on June 26, 2012. Dr. Clavell holds New Mexico license MD2017-0899.

Dr. Clavell's primary practice is Eye Associates of New Mexico, at 1817 Wellspring SE Ave, Rio Rancho, NM 87124 in Sandoval County. The practice phone is (505) 888-5757.

Dr. Clavell's primary practice is Eye Associates of New Mexico in Rio Rancho, New Mexico. Dmand AI also links Dr. Clavell to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clavell practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Clavell's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Clavell is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Clavell is licensed in New Mexico.

CMS data shows 3,420 Medicare services from Dr. Clavell across 9 procedure codes in 2024, for 243 Medicare patients. Medicare paid $209,879 for them. Every service was in an office.

CMS counts 243 Medicare patients who saw Dr. Clavell in 2026. The largest group is 65 to 74, with 97 patients. 69% of them have high blood pressure, and 68% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Clavell's median patient age at 74, with 56% women.

In 2026, Dr. Clavell wrote 350 Medicare Part D claims for 137 patients. 68% of them were for generic drugs. CMS names the drug for 271 of them, across 9 drugs with 11 or more claims each, at $5,443 in total drug cost. In 2023, CMS named 188 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Clavell for performance year 2026, reported through an alternative payment model (APM). Dr. Clavell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Clavell, published from 2024 to 2025. 2024 was the busiest year, with 3. Dr. Clavell has published most often in Am J Ophthalmol Case Rep. Dr. Clavell's most frequent co-authors are James Dossett, MD, Ghassan Richard Ghorayeb, MD and Nicole Marie Pumariega, MD.

CMS Open Payments shows 41 general payments to Dr. Clavell from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Genentech, Inc. paid the most, $3,165.